Charles Schwab’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
|
|||||
|
2025
Q1 | $41.2M | Buy |
|
|||||
|
2024
Q4 | $75.8M | Buy |
|
|||||
|
2024
Q3 | $76.4M | Buy |
|
|||||
|
2024
Q2 | $95.6M | Buy |
|
|||||
|
2024
Q1 | $76.3M | Buy |
|
|||||
|
2023
Q4 | $55.6M | Buy |
|
|||||
|
2023
Q3 | $67.9M | Buy |
|
|||||
|
2023
Q2 | $63.4M | Buy |
|
|||||
|
2023
Q1 | $71.7M | Buy |
|
|||||
|
2022
Q4 | $66.9M | Buy |
|
|||||
|
2022
Q3 | $54.7M | Buy |
|
|||||
|
2022
Q2 | $36.6M | Buy |
|
|||||
|
2022
Q1 | $37.4M | Buy |
|
|||||
|
2021
Q4 | $42.2M | Buy |
|
|||||
|
2021
Q3 | $38.7M | Buy |
|
|||||
|
2021
Q2 | $31.4M | Buy |
|
|||||
|
2021
Q1 | $29.4M | Buy |
|
|||||
|
2020
Q4 | $66.6M | Buy |
|
|||||
|
2020
Q3 | $54M | Buy |
|
|||||
|
2020
Q2 | $57.8M | Buy |
|
|||||
|
2020
Q1 | $33.1M | Buy |
|
|||||
|
2019
Q4 | $42.7M | Buy |
|
|||||
|
2019
Q3 | $24.5M | Buy |
|
|||||
|
2019
Q2 | $46.6M | Buy |
|
|||||
|
2019
Q1 | $33.5M | Buy |
|
|||||
|
2018
Q4 | $28.6M | Buy |
|
|||||
|
2018
Q3 | $38.5M | Buy |
|
|||||
|
2018
Q2 | $30.2M | Sell |
|
|||||
|
2018
Q1 | $23.7M | Buy |
|
|||||
|
2017
Q4 | $16.1M | Buy |
|
|||||
|
2017
Q3 | $12.2M | Buy |
|
|||||
|
2017
Q2 | $7.25M | Buy |
|
|||||
|
2017
Q1 | $6.07M | Buy |
|
|||||
|
2016
Q4 | $5.33M | Buy |
|
|||||
|
2016
Q3 | $10.4M | Buy |
|
|||||
|
2016
Q2 | $2.93M | Buy |
|
|||||
|
2016
Q1 | $2.95M | Buy |
|
|||||
|
2015
Q4 | $5.71M | Buy |
|
|||||
|
2015
Q3 | $4.16M | Buy |
|
|||||
|
2015
Q2 | $3.83M | Buy |
|
|||||
|
2015
Q1 | $1.47M | Sell |
|
|||||
|
2014
Q4 | $1.77M | Buy |
|
|||||
|
2014
Q3 | $2.31M | Buy |
|
|||||
|
2014
Q2 | $3.19M | Buy |
|
|||||
|
2014
Q1 | $2.35M | Buy |
|
|||||
|
2013
Q4 | $1.83M | Buy |
|
|||||
|
2013
Q3 | $3.74M | Buy |
|
|||||
|
2013
Q2 | $2.8M | Buy |
|